What Do We Know About Hypertrophic Cardiomyopathy in Poland in the Period 2016–2021 Based on Data From the Public Health System?
The study highlights significant underdiagnosis of HCM in Poland. Mortality in HCM population remains high, underscoring the need for improvement in earlier detection and comprehensive care strategies in Polish healthcare system.
Authors
- Maciej Podolski
- Magdalena Mizia
- Kinga Czepczor
- Maria Stec (ORCID: https://orcid.org/0000-0001-7205-3900)
- Małgorzata Niemiec (ORCID: https://orcid.org/0009-0002-3544-2311)
- Mariusz Gąsior (ORCID: https://orcid.org/0000-0001-6775-1392)
- Bartosz Gruchlik (ORCID: https://orcid.org/0000-0003-1070-5760)
- Urszula Cegłowska (ORCID: https://orcid.org/0000-0002-1300-7370)
- Kacper Hałgas
- Anna Wiśniewska (ORCID: https://orcid.org/0000-0003-0876-1763)
- Gabriela Bernadeta Orzeł-Łomozik
- Daniel Cieśla
- T Hryniewiecki
- Alida L P Caforio
- Jacek Grzybowski
- Przemysław Leszek
Institutions
- Valve (United States) (US)
- University of Padua (IT)
- Medical University of Silesia (PL)
- Health Education England (GB)
- Ministry of Health (PL)
- National Institute of Oncology (HU)
- Silesian Center for Heart Disease (PL)
- National Heart Institute (MY)
- ERN GUARD-Heart (NL)
Publication Details
- Journal
- International Journal of Public Health
- Published
- 2026-03-11
- DOI
- https://doi.org/10.3389/ijph.2026.1608693
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00